Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.
Coccidioidal meningitis (CM) is a devastating disease that requires long-term therapy and for which there is little hope of a cure. A model was used to compare the efficacies of itraconazole and fluconazole. CD-1 mice were infected intrathecally with 30 to 36 viable arthroconidia of Coccidioides. Oral therapy with cyclodextrin (control) or itraconazole or fluconazole at 10, 25, or 50 mg/kg of body weight twice daily (BID) was given for 12 days, from day 3 of infection. Treatment with both antifungals at all doses prolonged survival compared with that of the control treatment (P < 0.01 to 0.0001). At 50 mg/kg, itraconazole and fluconazole were equivalent, whereas itraconazole at 10 or 25 mg/kg prolonged survival compared to that achieved with fluconazole at these dosages (P < 0.05 and 0.01, respectively). Early histologic analysis (10 days of treatment) with 50 mg/kg BID itraconazole or fluconazole showed suppression of CM in all five animals per group; in quantitative cultures, three of three animals from each group had no detectable infection in the brain, spinal cord, or a site of secondary infection, the lungs. In contrast, four of seven controls showed mild to severe meningitis, with arteritis detected in three animals. In a short-term organ clearance study, 5 days of treatment with 10 or 50 mg/kg BID itraconazole or fluconazole reduced the tissue burdens in the brain and spinal cord compared to the tissue burdens in the controls (P < 0.02 to 0.0003). Fluconazole at 10 mg/kg did not reduce the fungal burden in secondary sites, the lungs and kidneys, whereas this itraconazole dose was more effective in clearing the fungi from both organs (P < 0.05 and P < 0.001, respectively). At 50 mg/kg, itraconazole and fluconazole were equivalent in clearing the fungi from the brain and kidney, but itraconazole was superior to fluconazole in clearing the fungi from the spinal cord and lungs (P < 0.05). Thus, both itraconazole and fluconazole were effective at controlling CM, but neither eliminated Coccidioides from tissues. Overall, itraconazole was more efficacious on an mg/kg basis; at high doses they were similarly effective.
Kamberi
Perparim
P
Division of Infectious Diseases, Department of Medicine, Santa Clara Valley Medical Center, 751 S. Bascom Ave., San Jose, CA 95128-2699, USA.
Sobel
Raymond A
RA
Clemons
Karl V
KV
Waldvogel
Andreas
A
Striebel
Joan M
JM
Williams
Paul L
PL
Stevens
David A
DA
D000818:Animals; D000935:Antifungal Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003045:Coccidioides; D003048:Coccidiosis / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D015169:Colony Count, Microbial; D004305:Dose-Response Relationship, Drug; D015725:Fluconazole / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007278:Injections, Spinal; D017964:Itraconazole / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D016921:Meningitis, Fungal / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D051379:Mice
D000935:Antifungal Agents; D017964:Itraconazole; D015725:Fluconazole